Published Date: 10 Mar 2023
According to a new study published in BMC Anesthesiology, the use of non-opioid anesthesia (OFA) is similar to opioid-based anesthesia (OA)...
Read Full NewsA new phase 2 study presented at AES 2025 showed that stiripentol may reduce seizure burden in patients with Lennox-Gastaut syndrome.
Sharon Hesterlee, PhD, President and CEO of the Muscular Dystrophy Association, discussed the 2026 MDA Conference, the significance of its keynote speaker, and the evolving therapeutic landscape in neuromuscular medicine.
A new study presented at AES 2025 examined factors linked to declining surgery for pediatric drug-resistant epilepsy and highlighted variability in candidate selection across centers.
The positive interim findings research represents the first clinical data for ETX101, an investigational cell-type-selective gene therapy, and the first potential one-time disease-modifying treatment for Dravet syndrome.
Lingdolinurad Demonstrates Dose-Dependent Serum Uric Acid Reductions
House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma
AI in Dermatology: Discussing Downsides to the Adoption of Artificial Intelligence
1.
Skinny melanoma incidence is associated with vitamin D deficiency.
2.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
3.
Scientists discover the 'roadmap' that aggressive cancer uses to spread
4.
Future of Lab-Developed Tests Still Taking Shape
5.
A radiotheranostic approach designed to combat aggressive cancers
1.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
2.
Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates
3.
The Lung Cancer Shift: From Reactive Treatment to Proactive Precision Medicine
4.
The Link Between Being Overweight and Cancer
5.
What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
Navigating the Complexities of Ph Negative ALL - Part XIV
5.
Navigating the Complexities of Ph Negative ALL - Part XVI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation